Argitalpenak (39) Jesús Manuel González Santiago argitalpenak

filter_list

2025

  1. Characterizing Hepatitis Delta in Spain and the gaps in its management

    Gastroenterologia y Hepatologia, Vol. 48, Núm. 2

  2. Evolving epidemiology of HCC in Spain

    JHEP Reports, Vol. 7, Núm. 5

  3. Management of Helicobacter pylori Infection in Spain Beyond the Data Collected in the European Registry on H. pylori Management (Hp-EuReg): Results of a Nationwide Survey

    Helicobacter, Vol. 30, Núm. 2

2024

  1. Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance

    American Journal of Gastroenterology, Vol. 119, Núm. 4, pp. 646-654

  2. Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition

    Biochemical Pharmacology, Vol. 228

  3. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 2, pp. 201-211

  4. Spontaneously ruptured hepatocellular carcinoma on non-cirrhotic liver: A prospective case series

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 683-690

2023

  1. Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on Helicobacter pylori Management (Hp-EuReg)

    Gut, Vol. 72, Núm. 11, pp. 2031-2037

  2. Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg)

    Gut, Vol. 72, Núm. 6, pp. 1054-1072

  3. Splenosis as an incidental finding in a patient with multifactorial anemia

    Revista espanola de enfermedades digestivas, Vol. 115, Núm. 4, pp. 188-189

2022

  1. Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia

    Hepatology, Vol. 76, Núm. 5, pp. 1259-1274

  2. Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of Helicobacter pylori Infection (Hp-EuReg)

    Journal of Clinical Medicine, Vol. 11, Núm. 12

  3. Efficacy and safety of cold versus hot snare polypectomy for small (5-9mm) colorectal polyps: A multicenter randomized controlled trial

    Endoscopy, Vol. 54, Núm. 1, pp. 35-44

  4. Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)

    Clinical Gastroenterology and Hepatology, Vol. 20, Núm. 10, pp. 2243-2257

  5. Location, morphology and invasiveness of lateral spreading tumors in the colorectum differ between two large cohorts from an eastern and western country

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 6, pp. 440-449

  6. Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study

    Liver International, Vol. 42, Núm. 8, pp. 1891-1901

  7. Radioembolisation with 90Y radiolabelled microspheres of hepatic tumour lesion with double aberrant vascular supply. Safe and easy treatment in the same operation

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 41, Núm. 2, pp. 110-112

2021

  1. Compound endoscopic morphological features for identifying non-pedunculated lesions ≥20 mm with intramucosal neoplasia

    Cancers, Vol. 13, Núm. 21

  2. Erratum: Efficacy and safety of cold versus hot snare polypectomy for small (5-9 mm) colorectal polyps: a multicenter randomized controlled trial (Endoscopy (2021) 53 DOI: 10.1055/a-1327-8357)

    Endoscopy

  3. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics

    Aging, Vol. 13, Núm. 19, pp. 23416-23434